Literature DB >> 22415388

Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence.

Steven C Yap1, H Thomas Lee.   

Abstract

Acute kidney injury (AKI) is a frequent complication in the intensive care unit with limited therapeutic modalities. Although survival from isolated AKI has improved with recent advancements in renal replacement therapy, mortality from AKI complicated by multiorgan dysfunction has remained unchanged and is estimated to be approximately 50%. Hence, defining and better understanding the pathophysiology of distant organ dysfunction associated with AKI is clinically important because it may lead to new treatment strategies. In animal models, it has become increasingly clear that AKI is not an isolated event but results in remote organ dysfunction involving the heart, lungs, liver, intestines, and brain through an inflammatory mechanism that involves neutrophil migration, cytokine expression, and increased oxidative stress. The purpose of this brief review is to summarize the human and basic science evidence for AKI and its detrimental effects on distant organs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415388     DOI: 10.1097/ALN.0b013e31824f951b

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  58 in total

1.  A new mouse model of hemorrhagic shock-induced acute kidney injury.

Authors:  Lei Wang; Jiangping Song; Jacentha Buggs; Jin Wei; Shaohui Wang; Jie Zhang; Gensheng Zhang; Yan Lu; Kay-Pong Yip; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2016-11-09

2.  σ1-Receptor Agonism Protects against Renal Ischemia-Reperfusion Injury.

Authors:  Adam Hosszu; Zsuzsanna Antal; Lilla Lenart; Judit Hodrea; Sandor Koszegi; Dora B Balogh; Nora F Banki; Laszlo Wagner; Adam Denes; Peter Hamar; Peter Degrell; Adam Vannay; Attila J Szabo; Andrea Fekete
Journal:  J Am Soc Nephrol       Date:  2016-04-07       Impact factor: 10.121

Review 3.  [Current techniques for extracorporeal decarboxylation].

Authors:  J Nentwich; S John
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-04-24       Impact factor: 0.840

4.  Histones and Neutrophil Extracellular Traps Enhance Tubular Necrosis and Remote Organ Injury in Ischemic AKI.

Authors:  Daigo Nakazawa; Santhosh V Kumar; Julian Marschner; Jyaysi Desai; Alexander Holderied; Lukas Rath; Franziska Kraft; Yutian Lei; Yuichiro Fukasawa; Gilbert W Moeckel; Maria Lucia Angelotti; Helen Liapis; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2017-01-10       Impact factor: 10.121

5.  Peptidyl arginine deiminase-4 exacerbates ischemic AKI by finding NEMO.

Authors:  May M Rabadi; Sang Jun Han; Mihwa Kim; Vivette D'Agati; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-03

Review 6.  Kidney-liver pathophysiological crosstalk: its characteristics and importance.

Authors:  Olivia Capalbo; Sofía Giuliani; Alberta Ferrero-Fernández; Paola Casciato; Carlos G Musso
Journal:  Int Urol Nephrol       Date:  2019-09-23       Impact factor: 2.370

Review 7.  Immunopathophysiology of trauma-related acute kidney injury.

Authors:  David A C Messerer; Rebecca Halbgebauer; Bo Nilsson; Hermann Pavenstädt; Peter Radermacher; Markus Huber-Lang
Journal:  Nat Rev Nephrol       Date:  2020-09-21       Impact factor: 28.314

8.  Treatment of critically ill children with kidney injury by sustained low-efficiency daily diafiltration.

Authors:  Chia-Ying Lee; Huang-Chieh Yeh; Ching-Yuang Lin
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

Review 9.  Kidney-brain crosstalk in the acute and chronic setting.

Authors:  Renhua Lu; Matthew C Kiernan; Anne Murray; Mitchell H Rosner; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

10.  Neonatal Acute Kidney Injury and the Risk of Intraventricular Hemorrhage in the Very Low Birth Weight Infant.

Authors:  Christine Stoops; Brian Sims; Russell Griffin; D J Askenazi
Journal:  Neonatology       Date:  2016-08-05       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.